| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone kinase activity | 5.58e-04 | 28 | 25 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.51e-03 | 46 | 25 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.84e-03 | 229 | 25 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.08e-03 | 875 | 25 | 5 | GO:0019904 | |
| MousePheno | abnormal medulla oblongata morphology | 8.59e-06 | 26 | 22 | 3 | MP:0000846 | |
| Domain | CUB | 5.15e-09 | 49 | 25 | 5 | PF00431 | |
| Domain | CUB | 5.71e-09 | 50 | 25 | 5 | SM00042 | |
| Domain | - | 6.99e-09 | 52 | 25 | 5 | 2.60.120.290 | |
| Domain | CUB | 7.72e-09 | 53 | 25 | 5 | PS01180 | |
| Domain | CUB_dom | 1.12e-08 | 57 | 25 | 5 | IPR000859 | |
| Domain | Hirudin/antistatin | 3.60e-05 | 7 | 25 | 2 | IPR011061 | |
| Domain | Growth_fac_rcpt_ | 5.17e-05 | 156 | 25 | 4 | IPR009030 | |
| Domain | Ephrin_rec_like | 9.39e-05 | 11 | 25 | 2 | PF07699 | |
| Domain | EGF_3 | 1.13e-04 | 12 | 25 | 2 | PF12947 | |
| Domain | EGF_dom | 1.13e-04 | 12 | 25 | 2 | IPR024731 | |
| Domain | Ephrin_rec_like | 5.06e-04 | 25 | 25 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.06e-04 | 25 | 25 | 2 | IPR011641 | |
| Domain | cEGF | 5.48e-04 | 26 | 25 | 2 | IPR026823 | |
| Domain | cEGF | 5.48e-04 | 26 | 25 | 2 | PF12662 | |
| Domain | Sushi | 2.19e-03 | 52 | 25 | 2 | PF00084 | |
| Domain | CCP | 2.36e-03 | 54 | 25 | 2 | SM00032 | |
| Domain | SUSHI | 2.53e-03 | 56 | 25 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.62e-03 | 57 | 25 | 2 | IPR000436 | |
| Domain | EGF_CA | 5.87e-03 | 86 | 25 | 2 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 7.41e-03 | 97 | 25 | 2 | IPR018097 | |
| Domain | EGF_CA | 7.71e-03 | 99 | 25 | 2 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.86e-03 | 100 | 25 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.79e-03 | 106 | 25 | 2 | IPR000152 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 12906867 | ||
| Pubmed | Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. | 1.49e-06 | 3 | 25 | 2 | 20697349 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 31991528 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 1.49e-06 | 3 | 25 | 2 | 12270931 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 25189770 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 20972425 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 23383134 | ||
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 8.87e-06 | 56 | 25 | 3 | 29184203 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 25639508 | ||
| Pubmed | Transcription factor Sox11 is essential for both embryonic and adult neurogenesis. | 2.22e-05 | 10 | 25 | 2 | 23483698 | |
| Pubmed | Multiple common variants for celiac disease influencing immune gene expression. | 2.23e-05 | 76 | 25 | 3 | 20190752 | |
| Pubmed | USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma. | 2.72e-05 | 11 | 25 | 2 | 35449157 | |
| Pubmed | MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2. | 2.72e-05 | 11 | 25 | 2 | 31856871 | |
| Pubmed | 3.26e-05 | 12 | 25 | 2 | 15140983 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 4.75e-05 | 571 | 25 | 5 | 37167062 | |
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 35333176 | ||
| Pubmed | 5.18e-05 | 15 | 25 | 2 | 17400507 | ||
| Pubmed | 6.38e-05 | 1006 | 25 | 6 | 15226823 | ||
| Pubmed | Functional analysis of candidate genes from genome-wide association studies of hearing. | 6.70e-05 | 17 | 25 | 2 | 31927188 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 33308444 | ||
| Pubmed | 1.03e-04 | 21 | 25 | 2 | 21953618 | ||
| Pubmed | RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer. | 1.47e-04 | 25 | 25 | 2 | 31636387 | |
| Pubmed | 2.13e-04 | 30 | 25 | 2 | 35152003 | ||
| Pubmed | Identification and characterization of SAP25, a novel component of the mSin3 corepressor complex. | 2.13e-04 | 30 | 25 | 2 | 16449650 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 2.21e-04 | 422 | 25 | 4 | 27342126 | |
| Pubmed | 3.25e-04 | 37 | 25 | 2 | 15342465 | ||
| Pubmed | 3.62e-04 | 39 | 25 | 2 | 24095980 | ||
| Pubmed | 4.40e-04 | 43 | 25 | 2 | 33472061 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 4.88e-04 | 942 | 25 | 5 | 31073040 | |
| Pubmed | PIKES Analysis Reveals Response to Degraders and Key Regulatory Mechanisms of the CRL4 Network. | 5.71e-04 | 49 | 25 | 2 | 31973889 | |
| Pubmed | 6.05e-04 | 551 | 25 | 4 | 34728620 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.94e-04 | 54 | 25 | 2 | 25631074 | |
| Interaction | SCUBE2 interactions | 8.85e-06 | 4 | 25 | 2 | int:SCUBE2 | |
| Interaction | SCUBE1 interactions | 1.47e-05 | 5 | 25 | 2 | int:SCUBE1 | |
| Interaction | OLFM1 interactions | 4.48e-05 | 56 | 25 | 3 | int:OLFM1 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.99e-04 | 57 | 15 | 2 | 1179 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.61e-03 | 181 | 15 | 2 | 694 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-05 | 129 | 25 | 3 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 144 | 25 | 3 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 144 | 25 | 3 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.76e-05 | 149 | 25 | 3 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.76e-05 | 149 | 25 | 3 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.76e-05 | 149 | 25 | 3 | 61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-05 | 153 | 25 | 3 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | Myeloid-F|World / shred on cell class and cell subclass (v4) | 8.56e-05 | 154 | 25 | 3 | 6d53eec4aefe54836bbfd314f28f5e9a24c2d833 | |
| ToppCell | normal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.03e-04 | 164 | 25 | 3 | fa2dae15b38cb8f9642dbf00549beec8ee19e9bb | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-04 | 170 | 25 | 3 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-04 | 175 | 25 | 3 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-04 | 183 | 25 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 184 | 25 | 3 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 192 | 25 | 3 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | wk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 192 | 25 | 3 | ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 193 | 25 | 3 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 193 | 25 | 3 | b53ffef20f918b7d1e9d3924562691d13245e2dd | |
| ToppCell | proximal-Epithelial-Serous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-04 | 195 | 25 | 3 | cb62f04f0e45bfb36eed2e7a3fc54d6d390b2ed1 | |
| ToppCell | proximal-Epithelial-Serous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-04 | 195 | 25 | 3 | 06b73abc1f32543f2a51db52dc6424a2a398fe0f | |
| ToppCell | proximal-3-Epithelial-Serous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-04 | 195 | 25 | 3 | 24a6a566143b04e37ad002e4c55037a0460ac2ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 196 | 25 | 3 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.74e-04 | 196 | 25 | 3 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.77e-04 | 197 | 25 | 3 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | NS-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-04 | 198 | 25 | 3 | e56417073e83061a43b9c41d6232d653904c1e90 | |
| ToppCell | NS-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-04 | 198 | 25 | 3 | 58f2bc88d92550fb0b7c2e46c63c49ec6777001c | |
| ToppCell | NS-critical-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-04 | 198 | 25 | 3 | fd5dd6d6d72356d4eac8637350405c69ccb7161c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 198 | 25 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 198 | 25 | 3 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | NS-critical-d_16-33-Myeloid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.80e-04 | 198 | 25 | 3 | 5602a78068ab6cccd4da1cc5566e68805820a295 | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-04 | 199 | 25 | 3 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-04 | 199 | 25 | 3 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| Computational | Neighborhood of RAD54L | 2.41e-04 | 105 | 13 | 3 | MORF_RAD54L | |
| Computational | Neighborhood of EI24 | 5.98e-04 | 143 | 13 | 3 | MORF_EI24 | |
| Computational | Neighborhood of RFC4 | 7.01e-04 | 151 | 13 | 3 | MORF_RFC4 | |
| Computational | Neighborhood of PPP1CC | 9.23e-04 | 166 | 13 | 3 | MORF_PPP1CC | |
| Computational | Neighborhood of NS | 1.03e-03 | 40 | 13 | 2 | GNF2_NS | |
| Computational | Neighborhood of PRKDC | 1.39e-03 | 191 | 13 | 3 | MORF_PRKDC | |
| Computational | Neighborhood of AATF | 1.79e-03 | 209 | 13 | 3 | MORF_AATF | |
| Computational | Genes in the cancer module 57. | 2.00e-03 | 56 | 13 | 2 | MODULE_57 | |
| Computational | Neighborhood of DEAF1 | 2.08e-03 | 57 | 13 | 2 | MORF_DEAF1 | |
| Computational | Neighborhood of XRCC5 | 2.51e-03 | 235 | 13 | 3 | MORF_XRCC5 | |
| Computational | TFs and nuclear. | 2.57e-03 | 237 | 13 | 3 | MODULE_252 | |
| Computational | Neighborhood of BUB1B | 2.77e-03 | 66 | 13 | 2 | MORF_BUB1B | |
| Computational | Neighborhood of EIF3S2 | 2.86e-03 | 246 | 13 | 3 | MORF_EIF3S2 | |
| Computational | Neighborhood of CDK2 | 3.29e-03 | 72 | 13 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of BUB3 | 4.00e-03 | 277 | 13 | 3 | MORF_BUB3 | |
| Computational | Neighborhood of HDAC2 | 4.12e-03 | 280 | 13 | 3 | MORF_HDAC2 | |
| Computational | Neighborhood of RAN | 4.66e-03 | 86 | 13 | 2 | GNF2_RAN | |
| Computational | Genes in the cancer module 198. | 5.14e-03 | 303 | 13 | 3 | MODULE_198 | |
| Computational | Neighborhood of GNB1 | 5.24e-03 | 305 | 13 | 3 | MORF_GNB1 | |
| Computational | Genes in the cancer module 567. | 5.89e-03 | 97 | 13 | 2 | MODULE_567 | |
| Computational | Neighborhood of RRM1 | 6.50e-03 | 102 | 13 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of PAPSS1 | 6.62e-03 | 103 | 13 | 2 | MORF_PAPSS1 | |
| Computational | Neighborhood of RAD23A | 7.56e-03 | 348 | 13 | 3 | MORF_RAD23A | |
| Computational | Neighborhood of DNMT1 | 8.61e-03 | 118 | 13 | 2 | MORF_DNMT1 | |
| Disease | respiratory symptom measurement, COVID-19 | 3.35e-05 | 74 | 25 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | attempted suicide | 4.50e-04 | 178 | 25 | 3 | EFO_0004321 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 7.28e-04 | 47 | 25 | 2 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | cognitive function measurement | 1.04e-03 | 1434 | 25 | 6 | EFO_0008354 | |
| Disease | Osteoporosis, Age-Related | 1.22e-03 | 61 | 25 | 2 | C0001787 | |
| Disease | Post-Traumatic Osteoporosis | 1.22e-03 | 61 | 25 | 2 | C0751406 | |
| Disease | Osteoporosis, Senile | 1.22e-03 | 61 | 25 | 2 | C0029459 | |
| Disease | Osteoporosis | 1.30e-03 | 63 | 25 | 2 | C0029456 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.52e-03 | 68 | 25 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | response to radiation | 2.52e-03 | 88 | 25 | 2 | GO_0009314 | |
| Disease | Adenoid Cystic Carcinoma | 3.24e-03 | 100 | 25 | 2 | C0010606 | |
| Disease | amyloid-beta measurement | 3.26e-03 | 355 | 25 | 3 | EFO_0005194 | |
| Disease | Drug Use Disorders | 4.26e-03 | 115 | 25 | 2 | C0013222 | |
| Disease | Drug Dependence | 4.26e-03 | 115 | 25 | 2 | C1510472 | |
| Disease | Drug habituation | 4.26e-03 | 115 | 25 | 2 | C0013170 | |
| Disease | Substance Dependence | 4.26e-03 | 115 | 25 | 2 | C0038580 | |
| Disease | Substance Use Disorders | 4.26e-03 | 115 | 25 | 2 | C0038586 | |
| Disease | Substance-Related Disorders | 4.26e-03 | 115 | 25 | 2 | C0236969 | |
| Disease | Drug abuse | 4.26e-03 | 115 | 25 | 2 | C0013146 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.26e-03 | 115 | 25 | 2 | C0029231 | |
| Disease | Prescription Drug Abuse | 4.26e-03 | 115 | 25 | 2 | C4316881 | |
| Disease | Substance abuse problem | 4.33e-03 | 116 | 25 | 2 | C0740858 | |
| Disease | neuroblastoma | 4.33e-03 | 116 | 25 | 2 | EFO_0000621 | |
| Disease | memory performance | 4.85e-03 | 409 | 25 | 3 | EFO_0004874 | |
| Disease | Squamous cell carcinoma | 4.93e-03 | 124 | 25 | 2 | C0007137 | |
| Disease | hip bone mineral density | 5.09e-03 | 126 | 25 | 2 | EFO_0007702 | |
| Disease | celiac disease | 5.09e-03 | 126 | 25 | 2 | EFO_0001060 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYPFPRCDAPCGYNV | 2136 | Q96PZ7 | |
| SPGYPDEYPNFQDCF | 2296 | Q7Z407 | |
| ESYDYQAACAPQPPG | 936 | Q9NY47 | |
| PAGVLSYQFCPDYFP | 86 | P30988 | |
| SYQFCPDYFPDFDPS | 91 | P30988 | |
| QPFQPEYPDSSFQCY | 1071 | Q6RI45 | |
| ADYCPECYPDNPANR | 46 | Q9H496 | |
| PYPNAPCFNNVAEYE | 46 | P83369 | |
| EGPPSYYDNQDFPAT | 136 | Q7Z429 | |
| ASYDFNDYDPDPQPR | 176 | Q6UW60 | |
| FPGADEPLQYPCQYS | 291 | O43318 | |
| YSPDFPDEYGPDRNC | 231 | Q8NCW0 | |
| EDPVYPFNNPAGCYA | 391 | Q9NZV1 | |
| DQYSEDFCQPPDFPC | 206 | Q12967 | |
| PNELPYNDYFEYFGP | 326 | Q92769 | |
| SPNYPGDYPANAECV | 811 | Q8IWY4 | |
| ESPNYPGNYPANTEC | 821 | Q9NQ36 | |
| YSYNPFDGPNENPEA | 176 | O15034 | |
| GFFICDQPYEPVSPY | 676 | P07814 | |
| ENPFLDNPDAFYYFP | 206 | P08567 | |
| DVPDAFYYCYSPDPG | 151 | O00186 | |
| PCFYPDEDDFYFGGP | 26 | P04198 | |
| PPQIFNGDRYCGDYD | 66 | Q9UJC5 | |
| YYENSPNFCEPNPET | 276 | P56703 | |
| PPYDPQCGIQSSEYF | 2286 | P78527 | |
| EPPFFNDDNMGPFYY | 6 | Q86XD8 |